Filing Details
- Accession Number:
- 0001267602-19-000188
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:20:36
- Reporting Period:
- 2019-11-01
- Accepted Time:
- 2019-11-19 16:20:36
- Original Submission Date:
- 2019-11-04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 200028718 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1762007 | Philip John Jones | 6120 Windward Parkway Suite 290 Alpharetta GA 30005 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-01 | 10,000 | $0.30 | 124,590 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares of common stock that were acquired by the reporting person on the open market.
- Reporting person's original Form 4 mistakenly reported Transaction Code "A".
- On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split. The amounts shown in Table I above reflect the amounts reported on the original Form 4. As of the date that this Form 4/A is filed, taking the reverse stock split into account, the amount shown in column 5 would be 8,306 shares.
Billionaire Hedge Funds
